What You Should Know:
- PCA Rx and Cost Plus Drugs, are joining forces to tackle the longstanding issue of opaque and inflated drug pricing in the US healthcare system.
- This landmark collaboration paves the way for greater transparency, accessibility, and affordability for employers and individuals nationwide.
Prioritizing Drug Pricing Transparency
By prioritizing transparency, this partnership empowers employers and members to make informed choices and fosters a more engaged
Read More
Drug-Pricing Transparency
Taking a Platform Approach to Drug Pricing Issues Can Help Unify Adversarial Sides
Healthcare is a notoriously complex industry with a multitude of stakeholders, many of whom find themselves in adversarial positions, simply due to the way the market operates. Ultimately, there is a shared goal of providing the best care to the patient. But as stakeholder relationships grow more complex, there can also be conflicts that drive wedges between parties and hamper successful collaboration.
We see this dynamic playing out in many areas of healthcare, but particularly in drug
Read More
Capital Rx Launches Clearinghouse Model to Bring Price Visibility to Prescription Drug Costs
Quick Glance- Capital Rx launches new innovative Clearinghouse Model, a new pricing framework that will itemize the actual unit cost for all drugs for the first time- The Clearinghouse Model will eliminate price variability for customers, ensuring that drug costs are the same for all customers.- Pharmacies in its retail network, which includes chains, like Walmart, Walgreens, to grocers and independent pharmacies, will be able to deliver the lowest prescription prices to customers.- While rising
Read More
Drug Pricing Transparency: Can Health IT Lower Drug Pricing for Patients?
Certain practices of pharmacy benefit managers (PBMs) have helped jack up drug prices to the point where many people can no longer afford their medications. For example, PBMs charge health plans considerably more for a drug than they pay pharmacies for the same medication. This “ingredient spread,” which generates much of the PBMs’ profits, results in health plans placing drugs into a higher-price tier. As a result, members’ copayments go up. Sometimes they’re higher than the cash prices for
Read More
